// App-Quantinova.ai

5066 : Impact of Brk-inhibitors on nondirectional and directed migration of breast cancer cells

Researchers

Presenter

  • Markus Oelze

Principal Investigators

  • Franziska I. Kluwe

  • Tom Wersig

  • Wolfgang Sippl

  • Andreas Hilgeroth

  • Christoph A. Ritter

Medical Centers

  • Ernst-Moritz-Arndt-Universitat Greifswald, Greifswald, Germany

  • Martin-Luther-University Halle-Wittenberg, Halle, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved